Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) 42.7% HIGHER; Endo International plc (Nasdaq: ENDP) announced that it has delivered a proposal to acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) for a per share consideration of $28.10 in a cash and stock transaction valued at $2.2 billion.
Infosonics Corp. (NASDAQ: IFON) 19.3% HIGHER; continued momentum from Tuesday
ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) 18% HIGHER; provides a corporate update on its plans to advance ICT-107 to a registrational phase III program in patients